Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $4.17 Million - $4.87 Million
-26,935 Closed
0 $0
Q1 2024

Aug 01, 2024

BUY
$159.82 - $182.1 $4.3 Million - $4.9 Million
26,935 New
26,935 $4.9 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Generate Investment Management LTD Portfolio

Follow Generate Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generate Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Generate Investment Management LTD with notifications on news.